The team at Invivo takes a unique approach to the study of the microbiome that not only emphasizes the connection between internal microbial populations and the wider ecological community, but also focuses on two types of microbiomes where little commercial work has been done.
Tune in to learn:
About a decade ago, Invivo was just a small startup company, but it’s since become well-regarded in the world of microbiome research, particularly for the work being done to better inform patients through their clinicians about the ways in which microbes affect individual health statuses.
The goal is to move further from the idea that there’s a “pill for every ill” and instead help people to understand their internal ecosystem, how it’s interacting with their immune response and contributing to the development of disease, and how they might manipulate it in order to improve their health.
In addition to looking at gastrointestinal microbiomes and trying to determine how to wield the data being derived in a way that will produce a clinical benefit for patients, the team at Invivo is also looking at the vaginal and oral microbiome.
Bacchus shares the techniques they’re using to obtain data, the types of markers they’ve found to be most important in the vaginal microbiome, the importance of making sense of the data and educating clinicians to do the same for their patients, and how critical it is to understand that microbes cannot be understood when looked at as separate from the host’s immune response.
Learn more at invivohealthcare.com.